ABVC BioPharma, Inc. (ABVC)

SG&A Expense Growth

39.63%

Fiscal year · Period ending:

ABVC logo

ABVC SG&A Expense Growth

Latest reported39.63%
ABVC FY SG&A Growth (YoY) (0.00% → 39.63%)
High-resolution chart · PNG

ABVC sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

ABVC BioPharma, Inc. SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
39.6318%
-9.3517%
-57.6154%
18.5603%
31.2623%
172.3471%
96.4414%
62.7476%
-3.0202%
215.9685%
1,209.5519%
-85.0484%
-85.553%
-39.9146%
-0.1189%
-45.0672%
-36.6513%
20.2085%
580.6782%
105.0909%
1,278.3219%
97.1238%
-41.415%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.